Maternal complications and the association with baseline variables in pregnant women with sickle cell disease

Hemoglobin

Volumn 37, Issue 3, 2013, Pages 219-226

  Al Farsi, Sharifa H ^a   Al Riyami, Nihal M ^a   Al Khabori, Murtadha K ^a   Al Hunaini, Mohammed N ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Complications; Pregnancy; Sickle cell disease

Indexed keywords

HEMOGLOBIN BETA CHAIN; HEMOGLOBIN D; HEMOGLOBIN F; HEMOGLOBIN S;

ADULT; ARTICLE; BLOOD TRANSFUSION; CAUSE OF DEATH; CESAREAN SECTION; COMORBIDITY; DISEASE ASSOCIATION; ECLAMPSIA; FEMALE; FOLLOW UP; GENOTYPE; GYNECOLOGIC INFECTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURE LABOR; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; UTERUS RUPTURE;

ADULT; ANEMIA, SICKLE CELL; FEMALE; GESTATIONAL AGE; HEMOGLOBIN, SICKLE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES;

EID: 84877838347     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2013.780249     Document Type: Article

References (13)

1. Serjeant GR. Sickle-cell disease. Lancet 1997;350(9079):725-730
2. Al-Riyami AA, Suleiman AJ, Afifi M, Al-Lamki ZM, Daar S. A community-based study of common hereditary blood disorders in Oman. East Mediterr Health J. 2001;7(6):1004-1011
3. Al-Riyami A, Ebrahim GJ. Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr. 2003;49(SUPPL1):11-20
4. Al Jama FE, Gasem T, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS. Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi Arabia. Arch Gynecol Obstetr. 2009;280(5):793-797
5. Morris JS, Dunn DT, Poddar D, Serjeant GR. Haematological risk factors for pregnancy outcome in Jamaican women with homozygous sickle cell disease. Br J Obstetr Gynaecol. 1994;101(9):770-773
6. Ou CN, Rognerud CL. Diagnosis of hemoglobinopathies: Electrophoresis vs. HPLC. Clin Chim Acta. 2001;313(1-2):187-194
7. Serjeant GR, Loy LL, Crowther M, Hambleton IR, Thame M. Outcome of pregnancy in homozygous sickle cell disease. Obstetr Gynecol. 2004;103(6):1278-1285
8. Dare FO, Makinde OO, Faasuba OB. The obstetric performance of sickle cell disease patients and homozygous Hemoglobin C disease patients in Ile-Ife, Nigeria. Int J Gynaecol Obstetr. 1992;37(3):163-168
9. Omo-Aghoja IO, Okonofua FE. Pregnancy outcome in women with sickle cell-A five year review. Nigerian Postgrad Med J. 2007;14(2):151-154
10. Leborgne-Samuel Y, Janky E, Venditelli F, et al. (Sickle cell anemia and pregnancy: Review of 68 cases in Guadeloupe). J Gynecol Obstetr Biol Reprod. 2000;29(1):86-93
11. Villers MS, Jamison MG, De Castro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obstetr Gynecol. 2008;199(2):125.e1-e5
12. Yu CK, Stasiowska E, Stephens A, Awogbade M, Davies A. Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic. J Obstet Gynaecol. 2009;29(6):512-516
13. Serjeant GR, Hambleton I, Thame M. Fecundity and pregnancy outcome in a cohort with sickle cell-Haemoglobin C disease followed from birth. BJOG. 2005;112(9):1308-1314